Recent advances in drug delivery strategies for treatment of ovarian cancer

作者: Payam Zahedi , Roshan Yoganathan , Micheline Piquette-Miller , Christine Allen

DOI: 10.1517/17425247.2012.665366

关键词: MicrosphereOncologyDISEASE RELAPSESystemic chemotherapySurgeryOvarian cancerDrugInternal medicineDiseaseDrug resistanceDrug deliveryMedicine

摘要: Introduction: Ovarian cancer is associated with the highest mortality rate of all gynecological malignancies, due in part to inadequate treatment strategies and asymptomatic nature disease. Current standard care includes surgery systemic chemotherapy. However, this approach can result toxicities eventual disease relapse, emergence multidrug resistance. Drug delivery systems (DDS) have shown promise overcoming many limitations facing conventional regimens. Areas covered: This review provides an overview recent advances DDS for ovarian cancers. Nano-sized systems, including nanoparticles, micelles, liposomes drug conjugates; microspheres; implants injectable depots are discussed. The advantages, clinical potential these also outlined. Expert opinion: enable passive targeting tumors their size, further improvements tumor localization be made u...

参考文章(178)
Derek Crowther, Ric Swindell, Malcolm R Ranson, Joseph A Prendiville, H Gurney, D Murphy, Heather Anderson, P Mayor, C H Buckley, V R Tindall, Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma. Annals of Oncology. ,vol. 1, pp. 427- 433 ,(1990)
Adrian L. Harris, Hypoxia — a key regulatory factor in tumour growth Nature Reviews Cancer. ,vol. 2, pp. 38- 47 ,(2002) , 10.1038/NRC704
Griffiths Ct, Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. National Cancer Institute monograph. ,vol. 42, pp. 101- 104 ,(1975)
Jindřich Kopeček, Jane Guo Shiah, C. Matthew Peterson, C. Anthony Peterson, Jing Ming Lu, Yongren Sun, Richard C. Straight, Combination Chemotherapy and Photodynamic Therapy with N-(2-Hydroxypropyl)methacrylamide Copolymer-bound Anticancer Drugs Inhibit Human Ovarian Carcinoma Heterotransplanted in Nude Mice Cancer Research. ,vol. 56, pp. 3980- 3985 ,(1996)
Ian F. Tannock, Tumor physiology and drug resistance. Cancer and Metastasis Reviews. ,vol. 20, pp. 123- 132 ,(2001) , 10.1023/A:1013125027697
Lia van Zuylen, Jaap Verweij, Alex Sparreboom, Role of formulation vehicles in taxane pharmacology. Investigational New Drugs. ,vol. 19, pp. 125- 141 ,(2001) , 10.1023/A:1010618632738
Seong Hoon Jang, M. Guillaume Wientjes, Dan Lu, Jessie L.‐S. Au, Drug delivery and transport to solid tumors. Pharmaceutical Research. ,vol. 20, pp. 1337- 1350 ,(2003) , 10.1023/A:1025785505977
W P McGuire, W J Hoskins, M F Brady, H D Homesley, W T Creasman, M L Berman, H Ball, J S Berek, J Woodward, Assessment of Dose-Intensive Therapy in Suboptimally Debulked Ovarian Cancer: A Gynecologic Oncology Group Study Journal of Clinical Oncology. ,vol. 13, pp. 1589- 1599 ,(1995) , 10.1200/JCO.1995.13.7.1589
A Jakobsen, K Bertelsen, J E Andersen, H Havsteen, P Jakobsen, K A Moeller, K Nielsen, E Sandberg, I Stroeyer, Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study. Journal of Clinical Oncology. ,vol. 15, pp. 193- 198 ,(1997) , 10.1200/JCO.1997.15.1.193